Laboratory Corp. (NYSE: LH) reported Q2 EPS of $1.77, $0.01 worse than the analyst estimate of $1.78. Revenue for the quarter came in at $1.42 billion versus the consensus estimate of $1.44 billion.

Laboratory Corp. sees FY2012 EPS of $6.80-$7.00, versus the consensus of $6.97. Laboratory Corp. sees FY2012 revenue increasing 2.0% - 3.0%.

For earnings history and earnings-related data on Laboratory Corp. (LH) click here.

Earnings Guidance Hot Guidance